批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2021/12/20 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/12/20 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1998/10/20 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:VERAPAMIL HYDROCHLORIDE 剂型/给药途径:SOLUTION;INTRAVENOUS 规格:5MG/2ML (2.5MG/ML) 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
018925 |
001 |
NDA |
VERAPAMIL HYDROCHLORIDE |
VERAPAMIL HYDROCHLORIDE |
SOLUTION;INTRAVENOUS |
5MG/2ML (2.5MG/ML) |
Prescription |
No |
No |
AP |
1984/03/30
|
EXELA PHARMA |
070737 |
001 |
ANDA |
VERAPAMIL HYDROCHLORIDE |
VERAPAMIL HYDROCHLORIDE |
SOLUTION;INTRAVENOUS |
5MG/2ML (2.5MG/ML) |
Prescription |
No |
Yes |
AP |
1987/05/06
|
HOSPIRA |
070738 |
001 |
ANDA |
VERAPAMIL HYDROCHLORIDE |
VERAPAMIL HYDROCHLORIDE |
SOLUTION;INTRAVENOUS |
5MG/2ML (2.5MG/ML) |
Prescription |
No |
Yes |
AP |
1987/05/06
|
HOSPIRA |
075136 |
001 |
ANDA |
VERAPAMIL HYDROCHLORIDE |
VERAPAMIL HYDROCHLORIDE |
SOLUTION;INTRAVENOUS |
5MG/2ML (2.5MG/ML) |
Prescription |
No |
Yes |
AP |
1998/10/20
|
HOSPIRA |
211015 |
001 |
ANDA |
VERAPAMIL HYDROCHLORIDE |
VERAPAMIL HYDROCHLORIDE |
SOLUTION;INTRAVENOUS |
5MG/2ML (2.5MG/ML) |
Prescription |
No |
No |
AP |
2018/06/18
|
SOMERSET THERAPS LLC |
211035 |
001 |
ANDA |
VERAPAMIL HYDROCHLORIDE |
VERAPAMIL HYDROCHLORIDE |
SOLUTION;INTRAVENOUS |
5MG/2ML (2.5MG/ML) |
Prescription |
No |
No |
AP |
2018/06/18
|
SOMERSET |
210994 |
001 |
ANDA |
VERAPAMIL HYDROCHLORIDE |
VERAPAMIL HYDROCHLORIDE |
SOLUTION;INTRAVENOUS |
5MG/2ML (2.5MG/ML) |
Prescription |
No |
No |
AP |
2018/07/13
|
AMNEAL |
211370 |
001 |
ANDA |
VERAPAMIL HYDROCHLORIDE |
VERAPAMIL HYDROCHLORIDE |
SOLUTION;INTRAVENOUS |
5MG/2ML (2.5MG/ML) |
Prescription |
No |
No |
AP |
2018/12/28
|
MICRO LABS |
213232 |
001 |
ANDA |
VERAPAMIL HYDROCHLORIDE |
VERAPAMIL HYDROCHLORIDE |
SOLUTION;INTRAVENOUS |
5MG/2ML (2.5MG/ML) |
Prescription |
No |
No |
AP |
2020/03/25
|
CAPLIN |
213352 |
002 |
ANDA |
VERAPAMIL HYDROCHLORIDE |
VERAPAMIL HYDROCHLORIDE |
SOLUTION;INTRAVENOUS |
5MG/2ML (2.5MG/ML) |
Prescription |
No |
No |
AP |
2020/09/16
|
NEPHRON |